Piper Sandler Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $7

Benzinga Newsdesk www.benzinga.com Positive 60.7%

Neg 0% Neu 0% Pos 60.7%

Piper Sandler analyst Biren Amin initiates coverage on Connect Biopharma Hldgs (NASDAQ:CNTB) with a Overweight rating and announces Price Target of $7.